GALECTIN THERAPEUTICS INC COM NEW
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for GALECTIN THERAPEUTICS INC COM NEW Equity, CUSIP 002980026.
Review SEC Form 13F institutional ownership, reported holding value and quarterly holder changes for GALECTIN THERAPEUTICS INC COM NEW Equity, CUSIP 002980026.